Soy isoflavone prodrugs target CB1 receptor to protect blood vessels from atherosclerosis
A research team at National Taiwan University found that abnormal blood flow activates CB1 receptors in endothelial cells, promoting vascular inflammation and dysfunction. Soy-derived isoflavone prodrugs that inhibit CB1 ...
Mar 24, 2026
0
6









